Historical salary details - Dr. James B. Breitmeyer, M.D.,PhD, President, Chief Executive Officer and Director, Oncternal Therapeutics Inc
Dr. James B. Breitmeyer, M.D.,PhD has been the President, Chief Executive Officer and Director of Oncternal Therapeutics Inc since 03 Dec 2019. View his historical salary.
Dr. James B. Breitmeyer, M.D.,Phd
President, Chief Executive Officer and Director
-
Gross Remuneration
-
Current Company
Oncternal Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | - | - |
| 2023 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 1.6 M | -32.6 % |
| 2022 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 2.4 M | -48.6 % |
| 2021 | Oncternal Therapeutics Inc | - | 4.7 M | 500.0 % |
| 2021 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 4.7 M | 500.0 % |
| 2020 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 781.8 K | -29.9 % |
| 2020 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 781.8 K | -29.9 % |
| 2020 | Oncternal Therapeutics Inc | - | 780.1 K | -30.1 % |
| 2019 | Oncternal Therapeutics Inc | - | 1.1 M | 115.4 % |
| 2019 | Oncternal Therapeutics Inc | - | 1.1 M | 115.4 % |
| 2019 | Oncternal Therapeutics Inc | President, Chief Executive Officer and Director | 1.1 M | 115.4 % |
| 2018 | Oncternal Therapeutics Inc | - | 518.0 K | - |
| 2018 | Oncternal Therapeutics Inc | - | 518.0 K | - |